COVID‐19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement

Patients on immunomodulators, including biologic agents and new small molecular inhibitors, for cutaneous disease, represent a potentially vulnerable population during the COVID‐19 pandemic. There is currently insufficient evidence to determine whether patients on systemic immunomodulators are at in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Australas J Dermatol
Main Authors: Wang, Charlie, Rademaker, Marius, Baker, Christopher, Foley, Peter
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262046/
https://ncbi.nlm.nih.gov/pubmed/32255510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajd.13313
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker